Search found 1 match
- Tue Jan 31, 2012 4:14 pm
- Forum: Tcelna (Tovaxin)
- Topic: Opexa (OPXA) Surges on FDA Fast-Track Designation.
- Replies: 34
- Views: 22189
Re: Opexa (OPXA) Surges on FDA Fast-Track Designation.
A larger phase IIb study was conducted by Dr. Ed Fox. This data compared two groups of MS patients. One group got Tovaxin and the second group got a placebo. These patients were followed for one year. While the Tovaxin group did better than the placebo group, the overall difference did not reach sta...